Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.

Panel 4 - Stakeholders' Perspective - North America Consumer Product Safety Summit

313 vues

Publié le

Regulatory cooperation should be relevant and responsive to real world challenges. This panel provides perspectives on new trends, products, and hazards and what can be done within the North America Cooperation framework. Points of focus: Cooperation and best practices, Policy Alignment, Consumer messaging.
Presenters: Agustin Adame, Consultant; Belinda May, ICPHSO President and Partner, Dentons US LLP; Carol Pollack-nelson, Ph.D. Independent Safety Consulting; Gene Rider, Eponent, Principal.

Les commentaires sont fermés

  • Soyez le premier à commenter

  • Soyez le premier à aimer ceci

Panel 4 - Stakeholders' Perspective - North America Consumer Product Safety Summit

  1. 1. Stakeholders  Manufacturers  Importers  Wholesalers and any other market agent  Academia (universities and institutes)  Consumers (NGO, individuals or groups)  Government (regulator and other agencies)  Others: Standardization and certification bodies and laboratories
  2. 2. Manufacturers  Experts on the product (designers and quality and safety assurance staff)  Incident Data  Consumer Feedback  Flaws detected in quality control  Consumer complaints  Modification of the product to eliminate or prevent the risk  Use of existing standards or quality testing protocols  Testing equipment  Certificates of compliance
  3. 3. Importers  Incident Data  Consumer complaints  Product traceability  Issues with import  Repairing possibilities by consumer or distributor  Recall procedure  Experts from manufacturer  Sales and Distribution data  Ingenious manufacturers’ report
  4. 4. Marketers or traders  Incident Data  Consumer complaints  Product traceability  Process for repairing or recalling the product.  Sales Data  Consumer feedback
  5. 5. Academia  Analysis of product failure  Bibliography  Testing method  Laboratory equipment  Mathematical models
  6. 6. Consumers  Incident data  Consumer complaints  Consumer expectations of the product  Communication infrastructure  Technical experts  Evaluation of corrective actions
  7. 7. Standardization and certification Bodies and Testing Laboratories  Existing or in-progress standards  Technical experts  Recognition of documents and test results from foreign organizations  Mathematical models for sampling  Laboratory equipment  Information and cancelation of certificates
  8. 8. Consumer Protection Agencies  Injuries data  Consumer complaints  Technical experts (Laboratory and Risk Analysis)  Communication with consumers  Communication with other government agencies  Communication with all stakeholders  Communications with other Consumer Protection agencies
  9. 9. Importance of Cooperation Between Consumer Protection Agencies  Similar level of protection for consumers  Together we are stronger  Alignment of standards  Laboratories  Similar proposals
  10. 10. Thanks Agustin Ary Adame Solorio ary_adame@yahoo.com.mx 52-55-40357853
  11. 11. Stakeholders’ Perspectives 2018 North America Consumer Product Safety Summit Belinda May Partner, Dentons US LLP ICPHSO President 2018-2019 May 4, 2018
  12. 12. Rich O'Brien, Director, Office of International Programs, U.S. CPSC Agustín Adame, Independent Product Safety Expert, Mexico Carol Pollack-Nelson, Ph.D., President, Independent Safety Consulting Gene Rider, Principal, Exponent Belinda May, Partner at Dentons & ICPHSO President May 4, 2018 Stakeholders North America Consumer Product Safety Summit Health Canada, Profeco & CPSC Government Consumers Service Providers Industry Manufacturers Retailers Academia Trade AssociationsConsumer Advocates Testing Organizations Standards Developers Interested Individuals Health & Safety Organizations Today's Stakeholders
  13. 13. May 4, 2018 14 Stakeholder Alignment PRODUCTS SAFETY INNOVATION UNIFIED COLLABORATION
  14. 14. • "It's always about the science" (financial science, engineering science, human science, process science...doesn't matter…it's always about the science) • US Fast Track model • "There's always a solution" • The "ICPHSO model" • Avoid Agency surprise Always - Belinda's "triple AAA rule" May 4, 2018 15 Stakeholder "Takeaways"
  15. 15. Thank you! Belinda May, Partner Dentons ICPHSO President 2018-2019 314-780-0999 belinda.may@dentons.com Dentons is the world's largest law firm, delivering quality and value to clients around the globe. Dentons is a leader on the Acritas Global Brand Index, a BTI Client Service 30 Award winner and recognized by prominent business and legal publications for its innovations in client service, including founding Nextlaw Labs and the Nextlaw Global Referral Network. Dentons' polycentric approach and world-class talent challenge the status quo to advance client interests in the communities in which we live and work. www.dentons.com. © 2018 Dentons. Dentons is a global legal practice providing client services worldwide through its member firms and affiliates. This publication is not designed to provide legal advice and you should not take, or refrain from taking, action based on its. Please see dentons.com for Legal Notices. content Month Day, Year 16
  16. 16. North American Consumer Product Safety Summit Carol Pollack-Nelson, Ph.D. Independent Safety Consulting May 4, 2014
  17. 17. Objective of a HF Analysis • How will consumer use product? - Foreseeable users - Uses, “Alternative” uses - Reasons & reasonableness for “misuse” 18
  18. 18. Participants in Voluntary Standard Development
  19. 19. ASTM Standard for Liquid Laundry Packets
  20. 20. ANSI Standard for Window Coverings
  21. 21. Infant Sleep Products
  22. 22. Thank You! 23
  23. 23. 2424 Tolerable Product Risk: El riesgo tolerable del producto: Presented By: Gene Rider Date: May 4, 2018
  24. 24. 25 • March 2009 1 Fatality / 100 million flights • Jan 2009 50 Fatalities / 100 million flights • Freak accident, public not to worry. • Marzo de 2009 1 muerte / 100 millones de vuelos • Enero de 2009 50 muertes / 100 millones de vuelos • Accidente extraño, el público no se preocupa. Tolerable Risk
  25. 25. 26 Risk Equation / La ecuación del riesgo Risk is the product of Exposure and Hazard El riesgo es el producto de la exposición y el peligro
  26. 26. 27 It is efficient to manage Risk by eliminating Hazards. Gestionar el riesgo eliminando los peligros, es eficiente. Risk Equation / La ecuación del riesgo 0 0
  27. 27. 28 Risk Assessment is a Probability La evaluación de riesgos es una probabilidad • Likelihood of Occurrence • Likely Consequence if it Occurs •La probabilidad de que ocurra •La consecuencia probable si ocurre
  28. 28. 29 Hazard Does Not Equal Risk • Consider the hazardous bottle cap on the right. • Millions are distributed annually. • They are a choking hazard. • Considere la tapa de botella peligrosa a la derecha. • Millones se distribuyen anualmente. • Presentan un peligro de asfixia. El peligro no es igual al riesgo
  29. 29. 30 Hazard Does Not Equal Risk – They are generally not available to young children. – They are not attractive to young children. – They do not have significant play value. • They do not present an unreasonable risk of injury. – Por lo general, no están disponibles para niños pequeños. – No son atractivas para los niños pequeños. – No tienen un valor de juego significativo. • No presentan un riesgo irrazonable de lesión. El peligro no es igual al riesgo
  30. 30. 31 4 Fatal Fatal 3 Hospital Hospital 2 Treated Atendido 1 Complaint Queja Property Damage Daño a la propiedad < 1 108 < 1 107 < 1 106 < 1 105 < 1 10⁴ < 1 10³ Likelihood of Occurrence Probabilidad de que ocurra Severity Gravedad Tolerable Risk / Riesgo Tolerable
  31. 31. 32 4 Fatal Fatal Category 2012-16 3 Hospital Hospital Category 2012-16 2 Treated Atendido Category 2012-16 1 Complaint Queja Property Damage Daño a la propiedad Category 2012-16 < 1 108 < 1 107 < 1 106 < 1 105 < 1 10⁴ < 1 10³ Likelihood of Occurrence Probabilidad de que ocurra Severity Gravedad Tolerable Risk / Riesgo Tolerable
  32. 32. 33 4 Fatal Fatal Category 2012-16 3 Hospital Hospital Category 2012-16 2 Treated Atendido Product A Category 2012-16 1 Complaint Queja Product A Property Damage Daño a la propiedad Product A Category 2012-16 < 1 108 < 1 107 < 1 106 < 1 105 < 1 10⁴ < 1 10³ Likelihood of Occurrence Probabilidad de que ocurra Severity Gravedad Tolerable Risk / Riesgo Tolerable
  33. 33. 34 Gene Rider, Principal Exponent, Inc. 420 Lexington Ave. Suite 1740 New York, NY 10170 grider@exponent.com 1.630.258.0522 Thank you Gracias

×